Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Breast Carcinoma
|
2793 | 0.658 | 0.400 | 17 | 7633209 | missense variant | G/A | snv | 8.9E-02 | 8.1E-02 | 0.060 | 0.833 | 6 | 2003 | 2012 | ||||
Malignant neoplasm of breast
|
3417 | 0.658 | 0.400 | 17 | 7633209 | missense variant | G/A | snv | 8.9E-02 | 8.1E-02 | 0.060 | 0.833 | 6 | 2003 | 2012 | ||||
Polycystic Ovary Syndrome
|
363 | 0.658 | 0.400 | 17 | 7633209 | missense variant | G/A | snv | 8.9E-02 | 8.1E-02 | 0.060 | 0.833 | 6 | 2004 | 2019 | ||||
Endometrial Carcinoma
|
326 | 0.658 | 0.400 | 17 | 7633209 | missense variant | G/A | snv | 8.9E-02 | 8.1E-02 | 0.020 | 1.000 | 2 | 2007 | 2008 | ||||
Male infertility
|
146 | 0.658 | 0.400 | 17 | 7633209 | missense variant | G/A | snv | 8.9E-02 | 8.1E-02 | 0.020 | 1.000 | 2 | 2011 | 2017 | ||||
Malignant neoplasm of endometrium
|
197 | 0.658 | 0.400 | 17 | 7633209 | missense variant | G/A | snv | 8.9E-02 | 8.1E-02 | 0.020 | 1.000 | 2 | 2007 | 2008 | ||||
Diabetes Mellitus, Non-Insulin-Dependent
|
2672 | 0.658 | 0.400 | 17 | 7633209 | missense variant | G/A | snv | 8.9E-02 | 8.1E-02 | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||
Gallbladder Carcinoma
|
75 | 0.658 | 0.400 | 17 | 7633209 | missense variant | G/A | snv | 8.9E-02 | 8.1E-02 | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||
Gestational Diabetes
|
224 | 0.658 | 0.400 | 17 | 7633209 | missense variant | G/A | snv | 8.9E-02 | 8.1E-02 | 0.010 | 1.000 | 1 | 2018 | 2018 | ||||
Language Disorders
|
25 | 0.658 | 0.400 | 17 | 7633209 | missense variant | G/A | snv | 8.9E-02 | 8.1E-02 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Liver carcinoma
|
942 | 0.658 | 0.400 | 17 | 7633209 | missense variant | G/A | snv | 8.9E-02 | 8.1E-02 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Lupus Erythematosus, Systemic
|
1172 | 0.658 | 0.400 | 17 | 7633209 | missense variant | G/A | snv | 8.9E-02 | 8.1E-02 | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||
Malignant neoplasm of gallbladder
|
81 | 0.658 | 0.400 | 17 | 7633209 | missense variant | G/A | snv | 8.9E-02 | 8.1E-02 | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||
Malignant neoplasm of prostate
|
1082 | 0.658 | 0.400 | 17 | 7633209 | missense variant | G/A | snv | 8.9E-02 | 8.1E-02 | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||
Metabolic Syndrome X
|
591 | 0.658 | 0.400 | 17 | 7633209 | missense variant | G/A | snv | 8.9E-02 | 8.1E-02 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Metastasis from malignant tumor of prostate
|
18 | 0.658 | 0.400 | 17 | 7633209 | missense variant | G/A | snv | 8.9E-02 | 8.1E-02 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Metastatic Prostate Carcinoma
|
24 | 0.658 | 0.400 | 17 | 7633209 | missense variant | G/A | snv | 8.9E-02 | 8.1E-02 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Osteoporosis
|
182 | 0.658 | 0.400 | 17 | 7633209 | missense variant | G/A | snv | 8.9E-02 | 8.1E-02 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Ovarian Cysts
|
3 | 0.658 | 0.400 | 17 | 7633209 | missense variant | G/A | snv | 8.9E-02 | 8.1E-02 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Ovarian Hyperstimulation Syndrome
|
24 | 0.658 | 0.400 | 17 | 7633209 | missense variant | G/A | snv | 8.9E-02 | 8.1E-02 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Prostate carcinoma
|
1168 | 0.658 | 0.400 | 17 | 7633209 | missense variant | G/A | snv | 8.9E-02 | 8.1E-02 | 0.010 | 1.000 | 1 | 2007 | 2007 | ||||
Schizophrenia
|
2897 | 0.658 | 0.400 | 17 | 7633209 | missense variant | G/A | snv | 8.9E-02 | 8.1E-02 | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||
Stage 0 Gallbladder Cancer AJCC v8
|
56 | 0.658 | 0.400 | 17 | 7633209 | missense variant | G/A | snv | 8.9E-02 | 8.1E-02 | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||
Stage IIA Gallbladder Cancer AJCC v8
|
56 | 0.658 | 0.400 | 17 | 7633209 | missense variant | G/A | snv | 8.9E-02 | 8.1E-02 | 0.010 | 1.000 | 1 | 2009 | 2009 | ||||
Stage IIB Gallbladder Cancer AJCC v8
|
56 | 0.658 | 0.400 | 17 | 7633209 | missense variant | G/A | snv | 8.9E-02 | 8.1E-02 | 0.010 | 1.000 | 1 | 2009 | 2009 |